Inclusion criteria  Availability, willingness and sufficient cognitive awareness to comply with examination procedures Bilateral implantation of one of the following IOL models Alcon PanOptix (TFNT00) PhysIOL FineVision (POD F) PhysIOL FineVision (POD F GF) Uneventful cataract surgery with first clinical outcomes in the expected range Patient included in Premium IOL study protocol by signed informed consent  Exclusion criteria  Age of patient <45 years Irregular astigmatism Postoperative manifested astigmatism of >1.0 D Difficulty for cooperation (distance from their home, general health condition) Clinically significant glaucoma Clinically significant macular degeneration, clinically significant macular edema or proliferative diabetic retinopathy Patients with keratoconus or keratectasia Any ocular comorbidity having a significant effect on the postoperative clinical outcomes History of ocular trauma or prior ocular surgery including refractive procedures Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome) Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions) AMD Intraoperative complications like capsular rupture etc. Patients who do not give informed consent